Amgen names Bradner CSO as Reese moves to CTO 

James “Jay” Bradner joined Amgen Inc. (NASDAQ:AMGN) as EVP of R&D and CSO, succeeding David Reese who will become EVP and CTO. Bradner was president of the Novartis Institutes for BioMedical Research (NIBR) for nearly seven years. 

Sofinnova Partners hired Matthieu Coutet as a partner, where he will contribute to the firm’s newly launched Biovelocita investment strategy for European biotech start-ups. Coutet was a managing partner at AdBio Partners...